Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES - amides - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-02 15:25:44 Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Amides Anti-diabetic drugs Peptide hormones Exenatide Anti-diabetic medication Sitagliptin Saxagliptin Metformin Glucagon-like peptide-1 agonist Sulfonylurea		Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES Add to Reading List Source URL: poisoncontrol.utah.edu Download Document from Source Website File Size: 1,00 MB Share Document on Facebook

	Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES DocID: 1oY1K - View Document
	glimepiride contraindications glimepiride doses glimepiride dehydration side effects of glimepiride glimepiride forum glimepiride tabs dosage, glimepiride max dose 10mg, glimepiride 2mg DocID: 1oLgD - View Document
	OctoberINSULIN USE FOR TYPE 2 DIABETES MANAGEMENT WHAT INSULIN REGIMEN SHOULD DocID: 1fAJ9 - View Document
	BYDUREON (exenatide extended-release for injectable suspension). DocID: 1dnVP - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA姞 (exenatide) Injection Initial DocID: 1ccpM - View Document